A History of the Concept of Atypical Depression
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Atypical depression is defined as a type of depression that responds preferentially to monoamine oxidase inhibitors. In addition to mood reactivity, symptoms of atypical depression include hypersomnia, hyperphagia or weight gain, leaden paralysis, and a long-standing pattern of rejection sensitivity or interpersonal sensitivity. Over the years, atypical depression has been associated with or identified as nonendogenous depression, anxiety, reverse vegetative shift, chronic pain, bipolar disorder, and rejection sensitivity. This presentation discusses the history of the identification of atypical depression, starting with its initial identification in 1959, and describes the important studies of atypical depression and its treatment by various research groups during the past 50 years. The presentation concludes by differentiating between typical and atypical depression and detailing of some of the clinical characteristics of atypical depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a large European study, it was found that only one fifth of anxiety patients sought help from healthcare services, and of these, one fifth received no treatment (Alonso et al. 2007).”
From World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders (2023) · cites this paper as Alonso et al. 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Drug Treatment of Psychiatric Disorders
Klein, D. F. (1970) · The British Journal of Psychiatry · doi:10.1192/s0007125000193523 · Cited by 563
Diagnosis and drug treatment of psychiatric disorders : adults and children
Klein, D. F. (1980) · Williams & Wilkins eBooks · Cited by 417
Effects of Iproniazid in Depressive Syndromes
West, E. D., & Dally, P. J. (1959) · BMJ · doi:10.1136/bmj.1.5136.1491 · Cited by 382
Tranylcypromine versus imipramine in anergic bipolar depression
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.7.910 · Cited by 360 · cited 2×
“Subsequently, Himmelhoch et al.9 examined the efficacy of the MAOI tranylcypromine versus imipramine for the acute treatment (first 6 weeks) and continuation treatment (next 10 weeks) of patients with bipolar depression with reversed vegetative features.”
BackgroundSelf-citationAntidepressant Specificity in Atypical Depression
Liebowitz, M. R. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800260037004 · Cited by 348 · cited 2×
“In 1988, Liebowitz et al.(24) reported on a 6-week, double-blind, randomized study of imipramine, phenelzine, and placebo in 119 patients who met the Columbia criteria for atypical depression.”
BackgroundKendler, K. S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050025004 · Cited by 323
The high prevalence of “Soft” bipolar (II) features in atypical depression
Perugi, G., Akiskal, H. S., Lattanzi, L., Cecconi, D., Mastrocinque, C., Patronelli, A., Vignoli, S., & Bemi, E. (1998) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(98)90080-3 · Cited by 304
Atypical Facial Pain and Depression
Lascelles, R. G. (1966) · British Journal of Psychiatry · doi:10.1192/bjp.112.488.651 · Cited by 217
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.3.306 · Cited by 198 · cited 2×
“At the same time, Quitkin et al.(25) demonstrated the superiority of phenelzine over placebo and imipramine in a group of patients with probable atypical depression, i.”
BackgroundHypersomnia and Manic-Depressive Disease
DETRE, T., HIMMELHOCH, J., SWARTZBURG, M., ANDERSON, C. M., BYCK, R., & KUPFER, D. J. (1972) · American Journal of Psychiatry · doi:10.1176/ajp.128.10.1303 · Cited by 170 · cited 2×
“In a small (N = 84) questionnaire-based study, Detre et al.(8)”
Background
Research works printed but not linked: 8
- Pollitt J, Young J. Anxiety state or masked depression? a study based on the action of monoamine oxidase inhibitors. Br J Psychiatry 1971;119: 143-149
- Raft D, Davidson J, Mattox A, et al. Double-blind evaluation of phenelzine, amitriptyline and placebo in depression associated with pain. In: Singer A, ed. Monoamine Oxidase: Structure, Function and Altered Functions. New York, NY: Academic Press; 1979:507-516
- Robinson DS, Nies A, Ravaris CL, et al. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive-anxiety states: a controlled clinical trial. Arch Gen Psychiatry 1973;29:407-413
- Quitkin FM, McGrath PJ, Stewart JW, et al. Atypical depression, panic J Clin Psychiatry 2007;68 (suppl 3) attacks, and response to imipramine and phenelzine: a replication. Arch Gen Psychiatry 1990;47:935-941
- Quitkin FM, Harrison W, Stewart JW, et al. Response to phenelzine and imipramine in placebo nonresponders with atypical depression: a new application of the crossover design. Arch Gen Psychiatry 1991;48: 319-323
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
- Vaishnavi S, Gadde K, Alamy S, et al. Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment. J Clin Psychopharmacol 2006;26:373-378
- Matza LS, Revicki DA, Davidson JR, et al. Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. Arch Gen Psychiatry 2003;60:817-826
Cited by
Epidemiology of anxiety disorders in the 21st century
Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/bbandelow · Cited by 2,079
Prevalence of antenatal and postnatal anxiety: Systematic review and meta-analysis
Dennis, C.-L., Falah-Hassani, K., & Shiri, R. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.187179 · Cited by 1,491
Fried, E. I., & Nesse, R. M. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.10.010 · Cited by 1,043
“Unfortunately, there has been limited success in identifying external validators for such qualitative subtypes (Davidson, 2007; Melartin et al., 2004; Pae et al., 2009; Young et al., 1987), and the debate about the number and nature of depression subtypes continues (Baumeister et al., 2011;…”
Depression sum-scores don’t add up: why analyzing specific depression symptoms is essential
Fried, E. I., & Nesse, R. M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0325-4 · Cited by 981
“There has been little agreement about the number and nature of depression subtypes [95-98], and limited success in identifying external validators for subtypes [99-102].”
BackgroundTreatment of anxiety disorders
Bandelow, B., Michaelis, S., & Wedekind, D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/bbandelow · Cited by 811
Depression Heterogeneity and Its Biological Underpinnings: Toward Immunometabolic Depression
Milaneschi, Y., Lamers, F., Berk, M., & Penninx, B. W. J. H. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.01.014 · Cited by 425
Downar, J., Geraci, J., Salomons, T. V., Dunlop, K., Wheeler, S., McAndrews, M. P., Bakker, N., Blumberger, D. M., Daskalakis, Z. J., Kennedy, S. H., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.026 · Cited by 337
“Examples include Leonhard’s (1) original distinction between unipolar and bipolar illness, as well as later proposed distinctions between melancholic and atypical depression (2), responsiveness to the dexamethasone suppression test (3), and the presence of agitation or mixed features (4).”
BackgroundMeta-review of depressive subtyping models
Harald, B., & Gordon, P. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.07.015 · Cited by 328
“The term ‘atypical’ originated from a historically reported poor treatment response to TCAs and a superior response to monoamine oxidase inhibitors (MAOIs) in patients with atypical depression (Davidson, 2007).”
BackgroundRevisiting the theoretical and methodological foundations of depression measurement
Fried, E. I., Flake, J. K., & Robinaugh, D. J. (2022) · Nature Reviews Psychology · doi:10.1038/s44159-022-00050-2 · Cited by 274
Animal models of anxiety disorders in rats and mice: some conceptual issues
Steimer, T. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.4/tsteimer · Cited by 242
McEvoy, P. M., Grove, R., & Slade, T. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.624083 · Cited by 229
The vigilance regulation model of affective disorders and ADHD
Hegerl, U., & Hensch, T. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.008 · Cited by 212
Simpson, W., Glazer, M., Michalski, N., Steiner, M., & Frey, B. N. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900806 · Cited by 208
Zucker, K. J., Lawrence, A. A., & Kreukels, B. P. C. (2016) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-021815-093034 · Cited by 196
The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder
Woelfer, M., Kasties, V., Kahlfuss, S., & Walter, M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.03.034 · Cited by 171
Recent advances in the neurobiology of anxiety disorders: Implications for novel therapeutics
Mathew, S. J., Price, R. B., & Charney, D. S. (2008) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30172 · Cited by 168
Meta-analysis of the prevalence of anxiety disorders in mainland China from 2000 to 2015
Guo, X., Meng, Z., Huang, G., Fan, J., Zhou, W., Ling, W., Jiang, J., Long, J., & Su, L. (2016) · Scientific Reports · doi:10.1038/srep28033 · Cited by 166
Depression in Primary Care: Current and Future Challenges
Craven, M. A., & Bland, R. (2013) · The Canadian Journal of Psychiatry · doi:10.1177/070674371305800802 · Cited by 168
Bandelow, B., Baldwin, D., Abelli, M., Altamura, C., Dell’Osso, B., Domschke, K., Fineberg, N. A., Grünblatt, E., Jarema, M., Maron, E., et al. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1181783 · Cited by 164
Ravens‐Sieberer, U., Erhart, M., Gosch, A., Wille, N., & The European KIDSCREEN Group (2008) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.574 · Cited by 163
Anxiety symptoms among Chinese nurses and the associated factors: a cross sectional study
Gao, Y.-Q., Pan, B.-C., Sun, W., Wu, H., Wang, J.-N., & Wang, L. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-141 · Cited by 161
Current status of brain imaging in anxiety disorders
Damsa, C., Kosel, M., & Moussally, J. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328319bd10 · Cited by 160
The anxiolytic effect of environmental enrichment is mediated via amygdalar CRF receptor type 1
Sztainberg, Y., Kuperman, Y., Tsoory, M., Lebow, M., & Chen, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.151 · Cited by 159
Bandelow, B., Allgulander, C., Baldwin, D. S., Costa, D. L. D. C., Denys, D., Dilbaz, N., Domschke, K., Eriksson, E., Fineberg, N. A., Hättenschwiler, J., et al. (2023) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2086295 · Cited by 158
Atypical depression: current perspectives
Łojko, D., & Rybakowski, J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s147317 · Cited by 118
“Type V was the one frequently seen in bipolar patients.(6) In 1994, the DSM-IV introduced the criteria for “atypical features” as a modifier of major depression and dysthymia.”
Mental disorders in young adulthood
Suvisaari, J., Aalto-Setälä, T., Tuulio-Henriksson, A., Härkänen, T., Saarni, S. I., Perälä, J., Schreck, M., Castaneda, A., Hintikka, J., Kestilä, L., et al. (2009) · Psychological Medicine · doi:10.1017/s0033291708003632 · Cited by 117
Giesbrecht, C. J., Mackay, J. P., Silveira, H. B., Urban, J. H., & Colmers, W. F. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2306-10.2010 · Cited by 107
Hollis, V., Konrad, A., Springer, A., Antoun, M., Antoun, C., Martin, R., & Whittaker, S. (2017) · Human–Computer Interaction · doi:10.1080/07370024.2016.1277724 · Cited by 103
Brăilean, A., Curtis, J., Davis, K. A. S., Dregan, A., & Hotopf, M. H. (2019) · Psychological Medicine · doi:10.1017/s0033291719001004 · Cited by 110
“Atypical depression (AD) is an intriguing clinical phenomenon that has been recognised since the late 1950s and has evolved as a syndrome of varying definitions (Davidson and Thase, 2007; Lojko and Rybakowski, 2017).”
BackgroundMackenzie, C. S., Karaoylas, E. C., & Starzyk, K. B. (2018) · Journal of Happiness Studies · doi:10.1007/s10902-017-9932-4 · Cited by 92
Atypical Depression: A Comprehensive Review
Pae, C., Tharwani, H. M., Marks, D. M., Masand, P. S., & Patkar, A. A. (2009) · CNS Drugs · doi:10.2165/11310990-000000000-00000 · Cited by 94
Harney, C., Johnson, J., Bailes, F., & Havelka, J. (2022) · Musicae Scientiae · doi:10.1177/10298649211046979 · Cited by 93
Zimmerman, M., McGlinchey, J. B., Chelminski, I., & Young, D. (2008) · Psychological Medicine · doi:10.1017/s0033291707001717 · Cited by 65
Review: A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)
Davidson, Jr., Zhang, W., Connor, K., Ji, J., Jobson, K., Lecrubier, Y., McFarlane, A., Newport, D., Nutt, D., Osser, D., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881108096505 · Cited by 63
Self-citationAzorin, J.-M., Aubrun, E., Bertsch, J., Reed, C., Gerard, S., & Lukasiewicz, M. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-33 · Cited by 62
Working alliance as a predictor of change in depression during blended cognitive behaviour therapy
Vernmark, K., Hesser, H., Topooco, N., Berger, T., Riper, H., Luuk, L., Backlund, L., Carlbring, P., & Andersson, G. (2019) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2018.1533577 · Cited by 59
McInnis, O. A., Matheson, K., & Anisman, H. (2014) · Anxiety, Stress, & Coping · doi:10.1080/10615806.2014.888060 · Cited by 59
Decreased Zinc and Increased Copper in Individuals with Anxiety
Russo, A. J. (2011) · Nutrition and Metabolic Insights · doi:10.4137/nmi.s6349 · Cited by 62
Gregory, K. D., Chelmow, D. P., Nelson, H. D., Niel, M. S. V., Conry, J. A., García, F., Kendig, S. M., O’Reilly, N., Qaseem, A., Ramos, D., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0580 · Cited by 66
Melatonin as a potential therapeutic agent in psychiatric illness
Maldonado, M. D., Reiter, R. J., & Pérez‐San‐Gregorio, M. A. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1032 · Cited by 54
Meng, X., & D'Arcy, C. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700806 · Cited by 53
Vitamin D3 supplementation and treatment outcomes in patients with depression (D3-vit-dep)
Hansen, J. P., Pareek, M., Hvolby, A., Schmedes, A., Toft, T., Dahl, E., & Nielsen, C. T. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4218-z · Cited by 72
Effects of pregabalin on sleep in generalized anxiety disorder
Holsboer-Trachsler, E., & Prieto, R. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000922 · Cited by 53
Olaya, B., Alonso, J., Atwoli, L., Kessler, R. C., Vilagut, G., & Haro, J. M. (2014) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796014000092 · Cited by 85
Shared Decision Making in Antipsychotic Management
Mistler, L. A., & Drake, R. E. (2008) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000341889.97759.54 · Cited by 56
Salivary cortisol and psychological mechanisms in patients with acute versus chronic low back pain
Sudhaus, S., Fricke, B., Stachon, A., Schneider, S., Klein, H., von Düring, M., & Hasenbring, M. I. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.10.011 · Cited by 55
“However, through years of research, atypical depression has been associated with chronic pain (Davidson, 2007).”
Wu, Y. H., Li, Z.-C., Yao, L., Li, M., & Mei, T. (2018) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0251 · Cited by 52
The Evolution of Antipsychotic Drug Therapy: Reserpine, Chlorpromazine, and Haloperidol
Preskorn, S. (2007) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000281486.34817.8b · Cited by 40
Montero-Marin, J., Garcia-Campayo, J., López-Montoyo, A., Zabaleta-del-Olmo, E., & Cuijpers, P. (2018) · Psychological Medicine · doi:10.1017/s0033291717003099 · Cited by 37
Stolerman, I. P., & Price, L. H. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_200815 · Cited by 36
NMDAR2B tyrosine phosphorylation regulates anxiety-like behavior and CRF expression in the amygdala
Delawary, M., Tezuka, T., Kiyama, Y., Yokoyama, K., Inoue, T., Hattori, S., Hashimoto, R., Umemori, H., Manabe, T., Yamamoto, T. S., et al. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-37 · Cited by 36
Lithium chloride treatment induces epithelial cell proliferation in xenografted human endometrium
Polotsky, A. J., Zhu, L., Santoro, N. F., & Pollard, J. W. (2009) · Human Reproduction · doi:10.1093/humrep/dep115 · Cited by 34
Fleury, M., Grenier, G., Bamvita, J., Perreault, M., & Caron, J. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-67 · Cited by 35
Bowens, N. H., Heydendael, W., Bhatnagar, S., & Jacobson, L. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.10.032 · Cited by 32
Recent Advances in Understanding and Treating Social Anxiety Disorder
Westenberg, H. G. M. (2009) · CNS Spectrums · doi:10.1017/s1092852900027267 · Cited by 34
Lo, H. H. M., Ng, S. M., & Chan, C. L. W. (2015) · Research on Social Work Practice · doi:10.1177/1049731514537686 · Cited by 26
Behavioral Activation for the Treatment of Atypical Depression: A Pilot Open Trial
Weinstock, L. M., Munroe, C., & Miller, I. W. (2011) · Behavior Modification · doi:10.1177/0145445511405646 · Cited by 27
“, 2002), and is associated with poorer response to pharmacologic treatment (Davidson, 2007).”
BackgroundCulpepper, L., & Kovalick, L. J. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0105 · Cited by 32
Atypical depression is more common than melancholic in fibromyalgia: an observational cohort study
Ross, R. L., Jones, K. D., Ward, R., Wood, L. J., & Bennett, R. M. (2010) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-11-120 · Cited by 27
“While several researchers have critiqued the current DSM-IV-TR criteria, as yet a viable alternative has not been agreed upon [14].”
BackgroundAdolescent Anxiety and TikTok: An Exploratory Study
Zheluk, A., Anderson, J., & Dineen‐Griffin, S. (2022) · Cureus · doi:10.7759/cureus.32530 · Cited by 32
Prevalence and correlates of depression with atypical symptoms in Hong Kong
Lee, S., Ng, K. L., & Tsang, A. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903279895 · Cited by 19
Nelson, H. D., Cantor, A. G., Pappas, M., & Weeks, C. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0579 · Cited by 26
Vincenzo, M. D., Sampogna, G., Rocca, B. D., Brandi, C., Mancuso, E., Landolfi, L., Volpicelli, A., Cerbo, A. D., Fiorillo, A., & Luciano, M. (2022) · Annals of General Psychiatry · doi:10.1186/s12991-022-00428-9 · Cited by 19
Bupropion extended-release for depressive disorders
Jefferson, J. W. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.5.715 · Cited by 18
Is atypical depression simply a typical depression with unusual symptoms?
Lyndon, B., Parker, G. B., Morris, G., Das, P., Outhred, T., Hamilton, A., Bassett, D. L., Baune, B. T., Berk, M., Boyce, P. M., et al. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417721020 · Cited by 14
“…labelled hysteroid dysphoria consisting of a subgroup of depressed female patients who demonstrated ‘an extreme response to admiration, approval and personal rejection’ and who also had symptoms of hypersomnia and hyperphagia (for a review of the history, see Davidson, 2007; Parker et al., 2002).”
BackgroundInfluentialPublic Health Perspectives on Depressive Disorders
Cohen, N. L. (2017) · Johns Hopkins University Press eBooks · doi:10.1353/book.52762 · Cited by 99
Transtorno afetivo bipolar na infância e na adolescência
Fu‐I, L. (2004) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462004000700006 · Cited by 27
Hunter, A. M., Ravikumar, S., Cook, I. A., & Leuchter, A. F. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01305.x · Cited by 16
Junkes, L., Quagliato, L. A., Appolinário, J. C., Shader, R. I., & Nardi, A. E. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107876 · Cited by 15
Is there a risk of esketamine misuse in clinical practice?
Roncero, C., Torres, M. M., Szerman, N., Torrens, M., Vega, P., Andrés-Olivera, P., & Alvarez, E. (2025) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986241310685 · Cited by 18
Navarro‐Mateu, F., Tormo, M., Vilagut, G., Alonso, J., Ruíz-Merino, G., Escámez, T., Salmerón, D., Júdez, J., Martínez, S., & Navarro, C. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-004035 · Cited by 15
Mood and anxiety profiles differentially associate with physical conditions in US adolescents
Stapp, E. K., Paksarian, D., He, J., Glaus, J., Conway, K. P., & Merikangas, K. R. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.11.056 · Cited by 8
Sachs‐Ericsson, N., Selby, E. A., Corsentino, E. A., Collins, N., Sawyer, K., Hames, J. L., Arce, D., Joiner, T. E., & Steffens, D. C. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31822cccff · Cited by 8
“Different portrayals of AD have emerged, and Davidson and Thase (15) assert that no single type of depression can be considered to be ‘atypical.”
BackgroundInfluentialPonizovsky, A. M., & Grinshpoon, A. (2009) · The Canadian Journal of Psychiatry · doi:10.1177/070674370905400608 · Cited by 8
A Historical Consideration of Psychiatric Diagnostic Systems : Focusing on the Concept of Depression
Kang, U. G., & Kim, H. (2014) · 신경정신의학 · doi:10.4306/jknpa.2014.53.5.259 · Cited by 8
Perestelo‐Pérez, L., Rivero‐Santana, A., Ramos‐García, V., Álvarez‐Pérez, Y., Duarte‐Díaz, A., Torres‐Castaño, A., Trujillo‐Martín, M. M., del Pino‐Sedeño, T., González‐González, A. I., & Serrano‐Aguilar, P. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039956 · Cited by 5
Focused on the negative: emotions and visuospatial attention in generalized anxiety disorder
Kalanthroff, E. (2023) · Anxiety Stress & Coping · doi:10.1080/10615806.2023.2262398 · Cited by 6
Co-occurring anxiety and depression: concepts, significance, and treatment implications
McGrath, P. J., & Miller, J. M. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.011 · Cited by 5
Increased Serum Cu/Zn Superoxide Dismutase in Individuals with Anxiety
Russo, A. J. (2010) · Proteomics Insights · doi:10.4137/pri.s5180 · Cited by 5
The Manifestation of Anxiety among Sesotho Speakers
Mosotho, N. L., Louw, D. A., Jacobus, F., & Calitz, W. (2011) · South African Journal of Psychology · doi:10.1177/008124631104100404 · Cited by 6
Jiménez-Sánchez, S., Jiménez‐García, R., Hernández‐Barrera, V., Villanueva‐Martínez, M., Ríos-Luna, A., Alonso‐Blanco, C., Palacios‐Ceña, D., & Fernández‐de‐las‐Peñas, C. (2011) · Journal of Musculoskeletal Pain · doi:10.3109/10582452.2011.558988 · Cited by 4
Extraversion modulates cortisol responses to acute social stress in chronic major depression
Chopra, K. K., Katz, J. L., Quilty, L. C., Matthews, S. G., Ravindran, A. V., & Levitan, R. D. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.02.008 · Cited by 6
The Role of Oxytocin in Neuropsychiatric Disorders: Concepts and Mechanisms
Levin, R., Edelman, S., Shalev, I., Ebstein, R. P., & Heresco‐Levy, U. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5_20 · Cited by 6
Substance misuse and its risk perception in European teenagers
Dzúrová, D., Spilková, J., & Vraný, M. (2015) · Children s Geographies · doi:10.1080/14733285.2015.1028895 · Cited by 5
Russo, A. J. (2010) · Nutrition and Metabolic Insights · doi:10.4137/nmi.s5495 · Cited by 4
Melo-Carrillo, A., Rodriguez, R., Ashina, S., Lipinski, B., Hart, P., & Burstein, R. (2023) · Psychology Research and Behavior Management · doi:10.2147/prbm.s388042 · Cited by 4
Lerner, Y., & Levinson, D. (2012) · Family Practice · doi:10.1093/fampra/cms017 · Cited by 3
Monoamine oxidase inhibitors for treatment-resistant depression
Bobo, W. V., & Richelson, E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00009-8 · Cited by 8
Jiang, M. Y. W., Kandris, E., Masry, Y. E., Drobny, J., Clare, T. S., & Chen, J. T.-H. (2021) · Clinical Psychologist · doi:10.1080/13284207.2021.1913048 · Cited by 4
Trouble bipolaire et douleur : au-delà de la souffrance
Olié, É., & Courtet, P. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0307-4_8 · Cited by 3
Defining and Differentiating Treatment-Resistant Depression
Treviño, K. (2012) · Cited by 3
Yerraguntla, H., Onyekachi, J., Nichtová, Z., Giacometti, L. L., Goldberg, S. L., Barson, J. R., Barker, J. M., & Reyes, B. A. S. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.02.026 · Cited by 2
Clinical and epidemiological predictors of treatment-resistant depression
Cusin, C., & Meyer, A. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00002-5 · Cited by 2
Recent advances in the biological treatment of mood disorders
McDonald, G., & Hallahan, B. P. (2009) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700000331 · Cited by 2
Fried, E. I. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-14966 · Cited by 3
“Consistency across and within these categories is low, atypical depression is difficult to distinguish from other MDD specifiers, and validity and reliability of the syndrome remain elusive (Davidson, 2007; Lam & Stewart, 1996; Pae, Tharwani, Marks, Masand, & Patkar, 2009).”
BackgroundBuchbauer, H., Adli, M., Schlattmann, P., Berger, M., Bschor, T., Stamm, T., Behr, J., Ricken, R., & Buspavanich, P. (2026) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.70127 · Cited by 2
“This subtype was introduced into the DSM due to findings of superior efficacy of monoamine oxidase inhibitors (MAOI) compared with tricyclic antidepressants (TCAs) in this subset of patients [15], underlining the relevance of subtypes for the selection of adequate treatment.”
Urbanos-Garrido, R. M., & Agúndez, L. (2025) · Applied Health Economics and Health Policy · doi:10.1007/s40258-025-00961-0 · Cited by 3
Schlaf – Fundament der Entspannung
Burch, C. (2021) · Springer eBooks · doi:10.1007/978-3-662-63513-1_10 · Cited by 1
Challenges in diagnosing pathological anxiety
Simpson, H. B., Neria, Y., Lewis‐Fernández, R., & Schneier, F. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.009 · Cited by 1
Lindeberg, S. I. (2012) · Socialmedicinsk tidskrift · doi:10.62607/smt.v88i6.43661
Metadata
- Authors
- Davidson, J. R. T., & Thase, M. E.
- Affiliations
- Duke Medical Center (US)
- Corresponding author
- Davidson, Jonathan R. T.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-02-15
- Volume
- 68
- Issue
- 02
- Pages
- e03
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2166644681
- Cited by
- 119
- References
- 30
- Citations by year
- 2026: 3 · 2025: 19 · 2023: 2 · 2022: 7 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 3 · 2017: 10 · 2016: 3 · 2015: 4 · 2014: 7 · 2013: 4 · 2012: 7
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Keywords
- atypical depression, monoamine oxidase inhibitors, mood reactivity, hypersomnia, hyperphagia, rejection sensitivity, chronic pain, bipolar disorder
- MeSH terms
- Clinical Trials as Topic, Depressive Disorder, Humans, Monoamine Oxidase Inhibitors, History, 20th Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.